[DIV28SUPER] Workshop on the Feasibility of Using Incapacitation Agents Against Terrorists

Jean Bidlack and I agreed this was a timely moment to make the proceedings of this 1986 workshop available. This workshop was organized by the University of Rochester.

The previous generation of our colleagues participated in this event, members of APA and CPDD are well represented in this discussion of the use of behaviorally active agents in terrorist event suppression contexts.

Ron Wood

https://urresearch.rochester.edu/institutionalPublicationPublicView.action?institutionalItemId=25408&versionNumber=1


Sent from my iPhone
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] NPR.org » 'Operation Delirium:' Psychochemicals A nd Cold War

An interview (audio or transcript) by ter gross with the New Yorker investigative reporter

http://m.npr.org/story/13


Sent from my iPhone
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

Re: [DIV28SUPER] OPERATION DELIRIUM

a video excerpt of some edgewood arsenal films is now available:

http://www.newyorker.com/online/blogs/newsdesk/2012/12/video-manufacturing-madness.html

On Mon, Dec 10, 2012 at 11:59 AM, Ronald Wood <ronaldwood@gmail.com> wrote:

"...Decades after a risky Cold War experiment, a scientist lives with secrets.  ..."

http://www.newyorker.com/reporting/2012/12/17/121217fa_fact_khatchadourian?currentPage=all

This is a riveting story of army supported psychopharmacology at Edgewood Arsenal.  

 

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28SUPER] [GRAYMAIL] Joint NIH Council Meeting re: Functional Integration of NIDA, NIAAA and NCI - Dec. 13

 

Dear Colleagues,

 

There will be a Joint Meeting of the National Advisory Council on Alcohol Abuse and Alcoholism, the National Advisory Council on Drug Abuse, and the National Cancer Advisory Board on December 13, 2012, 11:30 a.m. – 1:00 p.m. ET.  Dr. Lawrence Tabak, Principal Deputy Director, National Institutes of Health (NIH), will provide an overview of the Trans-NIH Substance Use, Abuse, and Addiction Functional Integration Plan.  Please note, the public is welcome to join the call  1-888-324-8014 (toll-free); Passcode is 4418818

Webmeeting: http://webmeeting.nih.gov/suaa/.   Attached for your information is a copy of the open agenda. The public is also invited to submit additional comments to SUAAinfo@nih.gov through Friday, December 28, 2012.   Best regards,

 

 

Jane E. Smither
Constituent Liaison
Office of Science Policy and Communications
National Institute on Drug Abuse/NIH
6001 Executive Boulevard
Room 5230 MSC 9591
Bethesda, MD  20892-9591
Telephone - (301) 443-6071
Fax - (301) 443-6277
E-mail - jsmither@nida.nih.gov

www.drugabuse.gov

 

 

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Bethesda, Maryland

AGENDA

Joint Meeting of the

National Advisory Council on Alcohol Abuse and Alcoholism, the National Advisory Council on Drug Abuse, and the National Cancer Advisory Board

December 13, 2012

11:30 a.m. to 1:00 p.m. ET

1-888-324-8014 (toll-free); Passcode is 4418818

Webmeeting: http://webmeeting.nih.gov/suaa/

Thursday, December 13, 2012 - OPEN

11:30 a.m. Call to Order

Lawrence A. Tabak, D.D.S., Ph.D., Principal Deputy Director, NIH

Review of Policy and Procedures

Justin D. Hentges, M.P.P., Special Assistant to the Principal Deputy Director, NIH

11:35 a.m. Overview of the Trans-NIH Substance Use, Abuse, and Addiction Integration Plan

Lawrence A. Tabak, D.D.S., Ph.D., Principal Deputy Director, NIH

12:05 p.m. Council Discussion

12:45 p.m. Public Comments*

1:00 p.m. Adjourn

*The public is invited to submit additional comments to SUAAinfo@nih.gov through Friday, December 28, 2012. The comments will be shared with the three Committees

 

 

 

You are receiving this message because you are part of The Association for the Treatment of Tobacco Use and Dependence (ATTUD) Listserv. To send a message to the entire listserv, send the email to ATTUD@LISTSRV.UCSF.EDU. To reply to a message to the entire listserv, please use "Reply All," and to respond individually to the email sender, use "Reply." This listserv is not moderated. Unless specifically stated, messages posted on this listserv represent only the views of the individuals posting the messages, and ATTUD does not endorse the accuracy of any "statements."

---

Use this link to unsubscribe from this mailing list.

[DIV28SUPER] OPERATION DELIRIUM

"...Decades after a risky Cold War experiment, a scientist lives with secrets.  ..."

http://www.newyorker.com/reporting/2012/12/17/121217fa_fact_khatchadourian?currentPage=all

This is a riveting story of army supported psychopharmacology at Edgewood Arsenal.  

 

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28SUPER] [GRAYMAIL] NIH PA-13-018 Administrative Supplements for Research on Sex/Gender Differences (Admin Supp)

The NIH Office of Research on Women's Health (ORWH) and participating ICs including NIDA released on November 13 the  FOA, PA-13-018 Administrative Supplements for Research on Sex/Gender Differences (Admin Supp).  Supplements will be funded by an ORWH set aside.    The earliest submission date is December 12, 2012 and the application due date is January 11, 2013.

 

As is the case for all administrative supplements, research proposed under this announcement must be within the original scope of the parent grant.  Applicants should propose research that, if successful, would contribute to a greater understanding of the implications of sex/gender differences (or similarities) in human health or disease outcomes.   Applicants may use the following approaches to address sex/gender comparisons:

 

• The addition of another group of subjects (human or animal) of the opposite sex when subjects of only one sex were used in the original study for comparative analyses of sex/gender. Applicants proposing to use subjects of only one sex/gender will be considered non-responsive UNLESS the data will be compared with those from the opposite sex within the administrative supplement period;   
• The addition of more subjects  (human or animal) of both sexes to sufficiently power a study that was insufficiently powered to conduct or detect a sex/gender difference (or similarity) in the original study; or 
•  The analyses of preexisting data where sex-specific data are included and power is sufficient, but a sex/gender analysis was not performed as part of the original study.

 

TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful.

If you have problems contact jpollock@mail.nih.gov     301-435-1309

The National Institute on Drug Abuse (NIDA)  at the National Institutes of Health is an agency of the United States Department of Health and Human Services 

[DIV28SUPER] APA Congressional Fellowship Porgram: online application open

Great opportunity- see below:

-----

Spend a year working on Capitol Hill

 

APA seeks applications for its Congressional Fellowship Program. This opportunity allows up to two psychologists to spend a year in Washington, D.C., where they receive first-hand experience with federal policymaking. Congressional Fellows work as special legislative assistants in congressional member or committee offices and engage in a diverse range of policymaking activities.  APA offers specialized Congressional Fellowships for midcareer professionals, experts in health and behavior issues, and developmental psychologists and clinicians with experience working with children.  The program offers a year-long stipend and funds to support relocation, travel, and the purchase of health insurance. For more information, visit http://www.apa.org/about/gr/fellows or call the Public Interest Government Relations Office at 202.336.5935.

 

Applications must be postmarked by Jan. 11, 2013.

--
Kelly Dunn, Ph.D.
Instructor
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network